Endocrinology - Obesity and lipids

Obesity is a serious health problem that is increasing in society. Overweight and obesity are important risk factors for heart disease. Many risk factors for heart disease have been suggested in overweight and obese people, including dyslipidemia and irritability. Adiponectin, a hormone released by adipose tissue, has both weight loss and weight loss properties. Numerous studies have explained the relationship between adiponectin and obesity in different populations. LDL cholesterol plays an important role in this "diabetic dyslipidemia" and is considered to be severely atherogenic, a greater cause than a clear indication of increased risk. A variation known as VLDL, low-density lipoprotein, appears to be particularly dangerous—but it appears that increasing HDL, high-density lipoprotein cholesterol, can control its harmful activity or no decrease associated with LDL counts.

  • Elevated Cholesterol
  • Elevated Triglycerides
  • Elevated Triglycerides
  • Obesity/Metabolic Syndrome

Related Conference of Endocrinology - Obesity and lipids

April 10-11, 2025

5th World Congress on Endocrine and Diabetes

Dubai, UAE
April 10-11, 2025

4th International Summit on Hormonal Disorders

Dubai, UAE
May 08-09, 2025

5th European Endocrinology and Diabetes Congress

Madrid, Spain
May 19-20, 2025

6th World Summit on Diabetes

Rome, Italy
June 04-05, 2025

4th World Congress on Diabetes and Pediatric Endocrinology

Edinburgh, Scotland
July 29-30, 2025

15th World Congress on Endocrinology and Diabetes

Paris, France
September 08-09, 2025

3rd World congress and Expo on Diabetes

Frankfurt, Germany
October 30-31, 2025

5th Annual Summit on Diabetes and Endocrinology

Paris, France
November 06-07, 2025

8th Annual Meeting on Diabetes and Endocrinology

Dubai, UAE
November 20-21, 2025

21st World Congress on Endocrinology & Diabetes

Paris, France

Endocrinology - Obesity and lipids Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in